Active Ingredient: PACLITAXEL
Proprietary Name: PACLITAXEL
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: 100MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A217877
Product Number: 001
Approval Date: Aug 19, 2025
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
